SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABTI Alpha-Beta Technology
ABTI 0.200+99,900.0%Jun 17 12:34 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wayners who wrote (76)5/13/1997 3:09:00 PM
From: biowa   of 572
 
Wayne,

There you go with those TA arguments again. Some day I really have to read up on that.

Myself, I'm a fundamentalist, and the fundamental I see is a lot of non-HIV NDA's from smaller caps not getting relatively smooth approval on seemingly good PIII results. Today I see GNSA FINALLY got approvable letter for Genesa system, MATX is still waiting on AccuSite, etc. If Betafectin is a huge statistical success, then ABTI will probably react well, if there's anything the FDA can quibble about on the other hand, they will.

By the way, if results are coming in June and a run-up is coming shouldn't we expect it soon?

Hoping you get those calls bought,
biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext